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G, a ubiquitous second messenger, relays external signals from
G protein-coupled receptors to networks of intracellular effectors,
including voltage-dependent calcium channels. Unlike high-
voltage-activated Ca2 channels, the inhibition of low-voltage-
activated Ca2 channels is subtype-dependent and mediated
selectively by G2-containing dimers. Yet, the molecular basis for
this exquisite selectivity remains unknown. Here, we used pure
recombinant G subunits to establish that the G22 dimer can
selectively reconstitute the inhibition of 1H channels in isolated
membrane patches. This inhibition is the result of a reduction in
channel open probability that is not accompanied by a change in
channel expression or an alteration in active-channel gating. By
exchanging residues between the active G2 subunit and the
inactive G1 subunit, we identified a cluster of amino acids that
functionally distinguish G2 from other G subunits. These amino
acids on the -torus identify a region that is distinct from those
regions that contact the G subunit or other effectors.
-1H channels  channel regulation  G dimers
Low-voltage-activated (LVA) Ca2 currents carried by 1HCa2 channels play well documented roles in the regulation
of neuronal excitability (1). 1H currents are important in the
perception and transmission of noxious stimuli (2) and in the
development of neuropathic pain after peripheral axonal injury
(3), and the 1H gene (CACNA1H) is a susceptibility locus for
childhood absence epilepsy (4). 1H channels are regulated by
kinases (5), redox potential (6), and the activation of G protein-
coupled receptors that generate membrane-delimited signals
(7–9). For example, in neurons of the dorsal root ganglion,
GABAB (10), adenosine A1 (11), and dopamine (7) receptor
activation produce a steady-state inhibition of 1H whole-cell
currents. Current inhibition is reproduced by photoreleased
GTPS and blocked by pertussis toxin pretreatment (10) and can
be voltage-independent. Thus, dopamine-mediated inhibition is
not temporarily reversed by a strong depolarizing pulse and is
replicated in excised membrane patches, manifesting as a de-
crease in the probability of opening of LVA 1H channels (7).
Analogously, G22 dimers elicit a voltage-independent inhibi-
tion of 1H whole-cell currents carried by recombinant channels
by binding directly to the II-III loop of the channel protein (9).
To date, 7 G and 12 G subunits have been identified in
mammalian systems, producing a large number of potentially
unique dimers that could differ in their interactions among
effectors (12). However, the complexity of these signals is
mitigated by the reality that the G1–4 subunits are 85%
identical in amino acid sequence (13). Thus, although there are
differences in potency and efficacy, G dimers containing any
of the G1–4 subunits can regulate many effectors, such as G
protein-activated inwardly rectifying K (GIRK) K channels (13,
14) and high-voltage-activated Ca2 channels (15–18). In sur-
prising contrast, only G dimers containing G2 decrease
whole-cell currents carried by recombinant 1H channels;
dimeric isoforms containing G(1,3–4) are not modulatory (9).
In this study, we took advantage of this remarkable differential
modulation to understand how this selectivity in G signaling is
achieved. Our results identify a cluster of amino acids that
functionally distinguish G2 from other G subunits and define
a region that is distinct from those regions on the -torus that
make contact with the -subunit or other effectors.
Results
G2-containing dimers selectively inhibit the activity of 1H
channels and do not inhibit the 1G channel, a T-type Ca2
channel homolog (9). Because the II-III loop of 1H channels
preferentially binds G2-containing subunits and confers cur-
rent inhibition to unregulated 1G channels (9), we hypothesized
that modulation of 1H channel gating by G22 was mediated
by the direct binding of G dimers to the channel protein and,
thus, would be membrane-delimited. To test this possibility, we
measured single-channel currents in membrane patches excised
from HEK-293 cells stably expressing 1H Ca2 channels, com-
paring the effects of pure, recombinant G22 and G12 dimers
(Fig. 1). ICa was activated by a depolarizing pulse to35 mV, and
control activity was monitored for 5–6 min before direct appli-
cation of either G isoform. 1H Ca2 channels active at 35
mV displayed diverse patterns of small openings (Fig. 1 A and
B) and full steady-state potential-dependent inactivation (data
not shown). After the application of G22 to the bath (x¯  2
nM), 1H channels opened less frequently, decreasing the aver-
age ensemble current (105 sweeps, concatenated from three
cells) to 45.7% of control (Fig. 1A). By contrast, bath application
of G12 (x¯  2 nM) did not change the frequency of single-
channel opening or decrease the average ensemble current
(Fig. 1B).
Fig. 1C illustrates the time course of channel modulation by
G22 from an exemplar recording of an excised patch with at
least two active 1H channels. For each sweep, a value of channel
open probability (NPo) was calculated from the ratio of the total
open time and the test pulse duration. G22 markedly de-
creased NPo and concomitantly increased the number of silent
sweeps (denoted by a solid circle, Fig. 1C). The decrease in NPo
ranged from 72% to 27% in seven patches and was accompanied
by a 181 57% increase in the number of null sweeps (Fig. 1D).
This degree of inhibition was close to maximal, because a
10-fold-higher concentration of G22 (x¯  20 nM) only de-
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creased NPo to 70.9  7.6% (n  3). Moreover, the G22-
induced decrease in NPo was not accompanied by an increase in
the latency to first opening (49.7  4.3 ms (control), 48.7  5.8
ms (22), n  3 cells, not significant) or by a change in the
single-channel conductance of 6.4 pS (Fig. 5C, which is published
as supporting information on the PNASweb site). The amplitude
distribution of the test-pulse currents before and after the
addition of G22 yielded average midpoints for the primary
conductance state (70% of openings) that were not different
from each other (0.419  0.003 pA (vehicle); 0.389  0.004
pA (22), at 35 mV). Nor did G22 alter the open-state
distribution of dwell times, which remained well fitted to the sum
of two exponentials with unchanged proportions (1  0.44 
0.07 ms (68%); 2  2.86  0.15 ms (32%), Fig. 5 A and B).
Therefore, a G22-elicited decrease in 1H whole-cell current is
the apparent consequence of a decrease in the number of
channel openings. By contrast, G12 (x¯  2 nM) had no effect
on NPo in five patches showing macroscopic currents (Fig. 1B
andD), consistent with its failure to modulate whole-cell current
in published overexpression studies (9). Finally, we tested for the
ability of G22 to inhibit 1H(GII-III) unitary currents. In
concert with its whole-cell behavior, G22 failed to decrease the
open probability of 1H(GII-III) chimeric channels (117  13%,
n  4) in which the II-III loop is replaced with that from
unregulated 1G channels (9). Taken together, these data, with
recombinant protein delivered at low nanomolar concentrations,
establish amodulation that is membrane-delimited, and selective
for G2, and clarify the elementary events underlying the
G22-elicited inhibition of whole-cell current. This modulation
differs fundamentally from the inhibition of N-, PQ-, and
R-type Ca2 channels that is mediated by all G subtypes (13,
17, 19).
Because of the difficulty of obtaining patches expressing a
single recombinant channel, our analysis of single-channel cur-
rents precluded a distinction between a G22-mediated change
in N, the number of active channels, and Po, the probability of
finding the channel open. Therefore, we used nonstationary
noise analysis to analyze the fluctuations in macroscopic current
caused by the opening and closing of 1H channels to determine
and compare the effect of G22 with that of G12 (20, 21). We
conducted variance analysis of the current elicited upon repo-
larization to 70 mV after a test pulse to 30 mV that was
optimized to produce maximal channel opening with no appar-
ent macroscopic inactivation. Fitted parameters from variance-
mean current plots (Fig. 2 A–C), indicate no change in single-
channel current current (i) or the maximal activity (Pomax) of an
active channel but rather, a Gx2-elicited change in the number
(N) of active channels in the membrane. Notably, the expression
of G12 increased the number of active channels in the mem-
brane, in contrast to G22, which reduced it.
Because cell-surface biotinylation experiments (9) suggested
that G22 did not reduce the surface expression of 1H chan-
nels, we interpreted the G22-elicited decrease in active chan-
nel number (N) to be the result of reduced channel activity. To
verify this interpretation, we used an 1H channel construct that
incorporates a hemagglutinin (HA) epitope on the large extra-
cellular loop of domain I (S5-H5). We evaluated surface expres-
sion of channels, using luminometry to monitor the levels of
chemiluminescence (22). 1H-HA channels are fully functional
and, like wild-type channels, are modulated by G22 (58.3 
7.4% inhibition at20 mV, n 12). Although the expression of
the G2 subunit alone did not affect the membrane expression
of 1H-HA channels, coexpression with either G1 or G2
significantly increased the membrane expression of channels
[45 3.2% of control (G12, n 54) and 59 4.8% of control
(G22, n  53); Fig. 2D]. These data likely explain the
G12-elicited increase in active channel number revealed with
noise analysis but cannot account for the reduction in functional
channel number mediated by G22. Thus, we conclude that
G22 markedly decreases 1H channel NPo solely by diminish-
ing the stochastic behavior of 1H channels.
The G subunit is a member of a large family of proteins that
share a highly conserved WD40 repeating motif. In the G
subunit, the seven repeating motifs define a circular propeller-
like structure, with each ‘‘blade’’ formed by four antiparallel
-strands designated a–d (13). Extensive mutational analysis has
A B
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Fig. 1. Recombinant G22, but not G12, inhibits 1H channel activity in patches excised from HEK-293 cells. (A and B) Shown are records and analysis of
single-channel ICa currents elicited by repeated (6-sec) test pulses to 35 mV from 90 mV. Five consecutive sweeps and the ensemble average of 105 sweeps
concatenated from three cells (bottom trace) recorded before (Left) and after (Right) reconstitution of 1 nM G22 (A) or G12 (B) into the patch. (C) Time course
ofNPo from two representative patches before and after adding G. Sequential exposure to vehicle (sweeps 1–50) and in sweeps 51–100 Gdimer: G22 (Left)
or G12 (Right). Blankinactive sweeps (Nulls) are indicated by filled circles arbitrarily drawn at 0.3 (NPo) for clarity. (D) Bar graphs plot mean SEM of the percent
reduction in NPo (Left) or percent increase in nulls (Right) elicited by G22 or G12 relative to vehicle exposure for each patch. Numbers are patches recorded
for each condition. *, P  0.05 compares vehicle with treatment groups by ANOVA.
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identified the top and side of the -torus as surfaces for
interaction with specific effectors, such as adenylyl cyclase,
phospholipase C-, and several ion channels (13). Interestingly,
these same surfaces also mediate the inactivation of the G
subunit as it reassembles into the : heterotrimer (13, 23).
To identify a nonhomologous set of residues in G2 that could
determine the observed specificity of G action, we mutated
candidate residues that were unique to G2 and predicted to be
surface-exposed based on the crystal structure of bovine G1.
We selected P140 (human 2 sequence), positioned at the end of
the outermost d-strand of blade 2 in G2, and residues sited on
the d-strand of blade 3 (Group A: V178, G179, A181) or on the
b- and c-strands of blade 2 (Group B: F111, S125). Together,
these solvent-exposed amino acids cluster to form distinct do-
mains on the surface of the G protein (Fig. 3D and Fig. 6, which
is published as supporting information on the PNAS web site)
and, thus, could form interaction sites that functionally distin-
guish G1 from G2.
Consistent with observations (9), the selective overexpression
of G2-containing dimers in HEK-293 cells expressing 1H
channels decreased whole-cell current at all voltages, reducing
peak current density to 50.1 12.4% of that recorded from cells
expressing GFP alone (Fig. 3A). Mutation of P140 in G2 to the
corresponding residue in G1 (P140A) restored current density
to levels that were indistinguishable from cells expressing G1
dimers (Fig. 3B andE). However, the reciprocal mutation inG1
(A140P) did not confer current inhibition. We hypothesized that
a spatially contiguous region onG2, the d-strand of blade 3, may
also be required for channel-modulatory activity. Indeed, mu-
tagenesis of the selected Group A residues on G2 to the
corresponding residues in G1 (V178T, G179T, and A181T)
restored current density to levels recorded in GFP-transfected or
untransfected cells (G2GA; Fig. 3 C and E). Because the
A B
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Fig. 2. G1 and G2 increase surface channel expression, but only G2
reduces active channel number. (A–C) Variance analysis of ICa whole-cell
currents. Tail currents were elicited from HEK-2931H-stable cells coexpressing
GFP and empty vector (pcDNA3) or GFP, G2, and either wild-type G2 or G1
by repolarization to70 mV after repetitive (50 times for 6 sec) test pulses to
30 mV (6 ms), from 90 mV. Shown are variance versus current plots fitted
to the function 2  i I(t)  I(t)2N (solid line). Superimposed is the mean
number of active channels in the patch (NpF). Notably, the number of active
channels (NpF) was increased with G12 expression but reduced with G22
expression compared with control (each n  4, P  0.05). Values for unitary
current (i) and Po
max were unchanged in each condition: control (i 0.73 0.06
pA, Po
max  0.57  0.03, n  4), G22 (i  0.81  0.04 pA, Po
max  0.60  0.03,
n 4), G1 (i 0.82 0.06 pA, Po
max 0.62 0.05, n 4). (D) Quantification
of the expressed levels of HA-tagged 1H channels by luminometry. Chemilu-
minescence from fixed TSA201 cells coexpressing HA-tagged 1H channels,
G2, and either empty vector G1 or G2 subunits. Intensity of photon emission
is expressed as relative light units (RLU). The histogram plots values for 1H
surface expression. Numbers indicate individual cells studied for each condi-
tion. *, P  0.05 compares control with treatment groups by ANOVA.
Fig. 3. Four residues are critical for G2-mediated inhibition of 1H channels.
Shown are records from HEK-293 1H-stable cells expressing various Gx2
dimers and analysis of ICa whole-cell currents. (A–C Left) Family of sample
currents recorded at Vm60,50,40,20,5, and10 mV (from Vhold
90 mV) from cells coexpressing GFP and G2 and either wild-type Gx (A) or
mutant Gx proteins 2A(P140A), 1P(A140P) (B); 2GA(V178S, G179S, A181S),
1PGA(A140P, S178V, S179G, S181A) (C). (A–C Right) (A) Histogram plots
mean  SEM of peak current density (pApF) obtained from full current–
voltage relationships (I–V). (B and C) Maximal current at each test depolar-
ization plotted to construct I–V relationships for cells expressing wild-type or
mutant G dimers. Current amplitude is expressed as pApF to correct for
differences in cell size. (D) Schematic model of WD2 and WD3, each showing
-strands (a–d) from G2. Locations of amino acids selected for mutation are
indicated: Group A (GA), Group B (GB), and residue 140. (E) Mean current
density (SEM) at 20 mV (I–V peak) is plotted for each Gx2 construct.
Dashed lines denote I-V peak (mean  SEM) for wild-type G2- or G1-
expressing cells for comparison. Numbers indicate cells recorded for each
condition. *, P  0.05 compares untransfected (untfx) peak current density
with that of Gx2-expressing cells by ANOVA.
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independent mutagenesis of P140 and Group A residues re-
moved inhibition, we reasoned that, together, these residues
might define a region critical for 1H channel interaction. In
combination with the mutagenesis of A140P, the reciprocal
mutation of Group A residues in G1 conferred channel-
inhibitory activity to G1 (G1PGA; Fig. 3 C and E) that notably
was identical to that of wild-type G2. Moreover, this set of
residues (P140, V178, G179, and A181) produced a channel-
inhibitory activity in G1 that was not mimicked by the G1PGB
mutant (A140P, Y111F, and N125S), highlighting the specificity
of the identified region for channel-inhibitory interactions
(Fig. 3E).
Because all G(1–4)x subunits stimulate GIRK1,4 channel
activity (13, 14), we tested each mutant in a GIRK1,4 whole-cell
channel assay to confirm activity. As expected, both G1- and
G2-containing dimers increased the conductance of GIRK
channels equivalently, eliciting an 4-fold stimulation that was
mimicked by G mutants that either lacked or possessed 1H
channel-inhibitory activity (Fig. 7, which is published as sup-
porting information on the PNAS web site). Thus, residue
swapping on blades 2 and 3 of G did not disrupt GIRK-
effector contact sites that map to other regions of the G
structure.
Based on our whole-cell studies, we anticipated that the
G2GA mutations would remove G2 activity, and the G1PGA
mutations would confer activity to recombinant proteins tested
for direct channel-inhibitory activity. We prepared recombinant
G protein encoding these mutant sequences. Unlike wild-type
G2, G2GA failed to decrease single-channel activity (Fig. 4A).
Neither the NPo nor the number of null sweeps was changed
within the 5-min recording period by G2GA added to each of
seven patches (Fig. 4 A, C, and D). By contrast, G1PGA
consistently and significantly reduced the single-channel open
probability, decreasing NPo by 56  6% and concomitantly
increased the number of silent sweeps by 186  50% (Fig. 4
B–D). These changes in single-channel activity fully replicate the
inhibitory activity of wild-type G2. Thus, candidate sites iden-
tified in our whole-cell studies provide the molecular basis for
G2 inhibitory activity.
Discussion
It is now well established that ion channels are direct down-
stream targets of G dimers. G dimers increase GIRK K
currents (13, 14) and persistent Na currents (24) and inhibit
high-voltage-activated Ca2 currents carried by N-, PQ- and
R-type Ca2 channels (19, 25). We show here that the inhibition
of 1H channels also depends on a direct G–channel interac-
tion. Only the dimeric isoform that binds to the II-III loop of 1H
channels, G22, inhibits 1H unitary current in the excised
patch, and 1H(GII-III) chimeric channels, to which G22 cannot
bind, are not inhibited by G22. However, even though this
inhibition is membrane-delimited, G22 neither slows the ki-
netics of channel opening to prolong the latency to first opening
nor shifts the voltage-dependence of channel activation. More-
over, inhibition cannot be temporarily relieved by a strong
depolarizing prepulse. Thus, the inhibition of 1H channels does
not possess the hallmarks of voltage-dependent inhibition of N-
and PQ-type channels transduced by G dimers (15, 25).
On the other hand, voltage-independent (VI) inhibition of
high-voltage-activated (HVA) channels manifests as a scaled
reduction in steady-state current (26) that is not reversed by
prepulse (27, 28). VI inhibition does not rely on a direct
G-channel interaction but, rather, may be the result of either
second-messenger-induced phosphorylation and internalization
of the channel pore protein (28–30) or the depletion of mem-
brane acidic phosphoinositides (PtdIns(4,5)P2) (26, 31) that
destabilizes channel activity. Here, we show that, althoughG22
effects a scaled reduction in current and reduces the number of
functional channels, 1H channels are not removed from the
plasma membrane, and channel activity is not destabilized in the
excised patch configuration, even with Ca2 chelation. Thus,
from our experiments, we conclude that the inhibition of 1H
channels by G22 defines a unique inhibitory behavior.
A B
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Fig. 4. After residue swapping, recombinant G1PGA2, but not G2GA2, inhibits 1H channel activity in the excised patch. Shown are records and analysis
of single-channel ICa currents elicited by repeated (6-sec) test pulses to 35 mV from 90 mV (Methods). (A and B) Five consecutive sweeps and the ensemble
average of 105 sweeps concatenated from three cells (bottom trace) recorded before (Left) and after (Right) reconstitution of 1 nM recombinant G2GA2 (A)
or G1PGA2 (B). (C) Time course of NPo from two representative patches. Sequential exposure to vehicle (sweeps 1–50) and in sweeps 51–100 Gx2 dimer:
G2GA2 (Left) or G1PGA2 (Right). Blankinactive sweeps (nulls) are indicated by filled circles arbitrarily drawn at 0.15 (NPo) for clarity. (D) Bar graphs plot
mean SEM of the percent reduction inNPo (Left) or percent increase in nulls (Right) elicited by G2GA2 or G1PGA2 relative to vehicle exposure for each patch.
Numbers indicate patches recorded for each condition. *, P  0.05 compares vehicle with treatment groups by ANOVA.
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Our experiments also identify a cluster of 4 aa (P140, V178,
G179, and A181) that can account for the specificity of G22
action on 1H channels. The loss of function upon removal of
these residues fromG2 and the complementary gain of function
upon their transfer to G1 argues strongly that these residues,
located on the outermost strand of blades 2 and 3, are essential
for the interaction of G2-containing dimers with 1H channels.
By contrast, multiple effector-binding regions on the -torus
have been found to be important for regulating HVA channel
activity. Early mutagenesis studies identified residues that clus-
ter on the top surface of the -torus and along the side of blade
1 within a binding surface shared by the GDP-bound form of the
-subunit (32). However, other regions that lie opposite to the
G-interaction surface, containing critical residues Y111 and
S189, also have been identified for their importance in G
subtype-selective potency (33, 34). Nonetheless, these regions
are not sufficient to confer inhibitory activity to inactive rat G5,
suggesting additional critical N-type Ca2 channel-interacting
sites remain to be identified (33). On the other hand, the
C-terminal 25 aa of the -torus can confer full G regulation
to both PQ-type Ca2 channels and GIRK K channels,
suggesting that blades 6 and 7 may form a common binding
surface on the -torus for these effectors (35).
Specificity in G signaling typically is achieved by coupling
specific heterotrimeric G proteins to distinct types of receptors
(36) and by unique responses among effector isotypes (36, 37).
Our data indicate that specificity can also be determined by
unique effector contact sites on the surface of the -torus. We
have identified a set of residues on G2 that can account for its
differential regulation of 1H channel activity. These residues
may not be the only sites of effector contact with 1H channels,
because other residues conserved across all G subtypes may
also be important structural determinants. Nevertheless, our
studies show that G subtype-selective activity can be deter-
mined by a few residues. This mode of selectivity allows G the
choice of effector for the transmission of its signal and raises the
possibility that, in the dorsal root ganglion, LVA Ca2 channels
are chosen for inhibition by G2.
Methods
Cell Culture and Transfection.HEK-293 cells stably expressing 1H
channels were cultured (9) and transiently cotransfected with
plasmids for GFPG2Gx in a ratio of 1:6:6 g by using CaPO4
as reported (9). Cells were cultured 2 days before overnight
plating for electrophysiological recording made 72 h after trans-
fection (9).
Molecular Biology. The residue 140, Group A, and Group B
mutations were introduced by using the QuikChange XL Site-
Directed Mutagenesis kit (Stratagene, La Jolla, CA) (see Sup-
porting Methods, which is published as supporting information on
the PNAS web site, for primer sequences). All mutations were
confirmed by sequencing (University of Virginia Sequencing
Facility), and coding regions were excised (BamH1XhoI) and
subcloned into the mammalian expression vector pcDNA3.1.
Generation of Recombinant Gx2. The coding regions from all
wild-type and mutant G1 or G2 constructs (Guthrie Research
Institute, Sayre, PA) were excised from pcDNA3.1 by BamH1
XbaI restriction digest and subcloned into pVL1393 baculovirus
transfer vector (BD BiosciencesPharmingen, San Diego, CA).
Constructs were validated by restriction enzyme digest, fragment
analysis, and sequencing. Recombinant Gx baculoviruses were
generated in Sf9 insect cells by using the BaculoGold system (BD
BiosciencesPharmingen), plaque purified, and a high-titer stock
prepared (36). Sf9 cells were infected at a MOI of 3 with
high-titer virus encoding for a [His]6-taggedGi1 and the desired
Gx and G2 subunits, cell membranes prepared, and the
extracts applied to a Ni2-NTA column. Gx2 subunits were
eluted from the Ni2-bound i subunit with AlF, ensuring the
recovery of correctly folded G dimers (36). The activity of
pure G dimers was verified by testing for PLC- activation in
synthetic lipid vesicles (37).
Electrophysiology. HEK-293 cells were recorded as described by
using an Axopatch 200A amplifier, and data were collected with
PCLAMP 9.2 software.
Single-channel. Currents from inside-out excised patches were elic-
ited by a test pulse to 35 or 40 mV from 90 mV (200 msec,
6-sec interpulse) (38). Currents were filtered at 2 kHz and sampled
at 100 kHz. The external (pipette) solutionwas 75mMCsCl, 60mM
CaCl2, and 10 mM Hepes, pH 7.4 (with CsOH). The bath solution
was 140 mM potassium-aspartate, 5 mMMgCl2, 10 mMEGTA, 20
mM Hepes, pH 7.4 (with KOH), 0.162 mM CHAPS (0.01%), and
0.04mMDTT. PurifiedG subunits were diluted in bath solution.
At the end of each recording, the exact G concentration (1–20
nM) was determined from the measured bath volume. Analysis of
single-channel records was performed by using Clampfit 9.2 (Axon
InstrumentsMolecular Devices, Sunnyvale, CA) using the 50%
threshold crossing criterion for event detection (further details in
Supporting Methods).
Whole-cell. Currents were elicited as described (9). The internal
(pipette) solution was 115mMCsCl, 1 mMTBACl, 1mMMgCl2,
5 mM Mg-ATP, 1 mM Li-GTP, 20 mM Hepes, pH 7.2 (with
CsOH), and 11 mM BAPTA; added CaCl2 fixed free Ca2 at 27
nM (0.9 mM). The bath solution was 127 mM TEACl, 10 mM
CaCl2, 0.5 mMMgCl2, 10mMHepes, 5 mMdextrose, and 32mM
sucrose, pH 7.4 (with CsOH). Currents were filtered at 2 kHz
and sampled at 12.5 kHz, and leak subtraction was performed on
line by using scaled hyperpolarizing steps of one-fourth ampli-
tude (PN4). ANOVA was used for statistical examination with
post hocDunnett’s test, where significance was taken as P 0.05.
Data are given as mean  SEM.
Noise analysis. Tail currents were elicited by 70 mV after
repetitive (6-sec) test pulses (6 msec, 30 mV, from 90 mV)
from HEK-293 cells stably expressing 1H channels. The
internal (pipette) solution was identical to that described
above for whole-cell recording. Bath solution replaced Ca with
Ba to reduce charge screening: 117 mM TEACl, 20 mM BaCl2,
0.5 mM MgCl2, 10 mM Hepes, 5 mM dextrose, and 32 mM
sucrose, pH 7.4 (adjusted with CsOH). Currents were filtered
at 5 kHz and sampled at 25 kHz; leak subtraction was
performed on line by using scaled hyperpolarizing steps of
one-fourth amplitude (PN4). ANOVA was used for statistical
examination with post hoc Dunnett’s test, where significance
was taken as P  0.05.
Nonstationary Noise (Variance) Analysis. Briefly, [I(t)] for each
isochrone was used to compute the experimental nonstationary
ensemble variance. To correct for basal noise, the average
variance at 90 mV was subtracted from that obtained during
the test pulse. The subtracted variance (2) of the tail current
(70 mV) was plotted versus the mean current and the data
fitted to (20) 2  iI(t)  I(t)2N, where i  single-channel
current amplitude, and N  number of active channels. i was
obtained from the initial slope and N from nonlinear curve-
fitting analysis performed using Origin (OriginLab, Northamp-
ton, MA). The maximum open probability, Po
max, was obtained
from the relationship: Po
max  ImaxiN, where Imax is the maxi-
mum mean current measured in the experiment.
Surface ExpressionMeasurements.TSA201 cells cultured in 24-well
plates were transiently transfected by using Fugene 6 (Roche,
Basel, Switzerland) with plasmids for 1H-HA, (Cav3.2-HA-
GFP-pEGFP-C), G2, and either the G1 or G2 at a 1:1:1 ratio
(0.5 g of DNA per well). The culture medium (Invitrogen) was
14594  www.pnas.orgcgidoi10.1073pnas.0603945103 DePuy et al.
changed 24 h after transfection and the luminometric assay
performed as described (22) on 4% paraformaldehyde-fixed
cells. Primary and secondary antibodies used for 1H channel
detection were a monoclonal rat anti-HA (clone 3F10; Roche
Applied Science) and a horseradish peroxidase (The Jackson
Laboratory, Bar Harbor, ME), respectively (further details in
Supporting Methods). Eleven independent sets of transfections
were performed for each condition and results presented as
mean  SEM (P  0.05).
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